Development of a new type of influenza subunit vaccine made by muramyldipeptide-liposome: enhancement of humoral and cellular immune responses
- 1 October 1990
- Vol. 8 (5), 503-509
- https://doi.org/10.1016/0264-410x(90)90254-j
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Muramyl peptides: Immunomodulators, sleep factors, and vitaminsMedicinal Research Reviews, 1984
- Immune response to human influenza virus hemagglutinin expressed in Escherichia coliGene, 1983
- The Interaction of Influenza Virus Haemagglutinin with Phospholipid Vesicles -- Morphological and Immunological StudiesJournal of General Virology, 1981
- Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes.The Journal of Experimental Medicine, 1980
- Vaccination of Experimental Monkeys Against Plasmodium falciparum : A Possible Safe AdjuvantScience, 1978
- Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivativesBiochemical and Biophysical Research Communications, 1974
- The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B virusesEpidemiology and Infection, 1972
- A New Subunit Influenza Vaccine: Acceptability Compared with Standard Vaccines and Effect of Dose on AntigenicityThe Journal of Infectious Diseases, 1972
- An Outbreak of Influenza A2 in a Population with a Known Antibody ProfileThe Journal of Infectious Diseases, 1966
- Serological Responses and Clinical Reactions to Influenza Virus VaccinesBMJ, 1960